Reaction
Intestinal Metastasis reporting signals
As of the last recalculation, Intestinal Metastasis appears in 347 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is FULVESTRANT (PRR 68.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Fulvestrant | 34 | 68.3 | 68.4 |
| Octreotide Acetate | 27 | 57.2 | 57.3 |
| Trametinib | 21 | 55.4 | 55.5 |
| Dabrafenib | 18 | 54.0 | 54.0 |
| Ribociclib | 21 | 42.4 | 42.4 |
| Regorafenib | 8 | 42.3 | 42.3 |
| Letrozole Tablets | 28 | 37.9 | 37.9 |
| Panitumumab | 9 | 35.4 | 35.4 |
| Durvalumab | 10 | 30.3 | 30.3 |
| Rucaparib | 4 | 27.5 | 27.5 |
| Olaparib | 7 | 20.5 | 20.5 |
| Atezolizumab | 11 | 17.5 | 17.5 |